Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot Infections

An Open-label, Randomized Study Comparing the Efficacy and Safety of Piperacillin/Tazobactam and Ampicillin/Sulbactam Administered Intravenously in the Empirical Treatment of Foot Infections in Diabetic Inpatients

Phase IV Open-Label Foot Infection Study is being conducted to generate comparative Efficacy and Safety data in Diabetic Inpatients.

Inclusion Criteria

• Patients with diabetes mellitus
• Inpatient
• Have 1 or more infected ulcer(s) below the ankle

Exclusion Criteria

• Must not have gangrene or severely impaired arterial supply in your foot
• Must not have a bone infection in the area of your ulcer
• Must not have allergies to penicillins